SNPS

Synopsys

$396.17

-8.06%
Nov 20, 2026
Bobby Quantitative Model
Synopsys is the largest pure-play provider of electronic design automation (EDA) software and semiconductor intellectual property, supplying the design, verification, and signoff tools that chipmakers and systems companies use to architect complex silicon—a business now being reshaped by the transformational Ansys acquisition that pushes Synopsys into multiphysics simulation and systems-level design. The company operates as a de facto duopolist alongside Cadence in core EDA, with its position reinforced by mission-critical, subscription-like license and maintenance revenue (roughly $1.0B of the latest quarter's $2.48B) and sticky multi-year customer relationships across TSMC, Nvidia, and hyperscalers. The current investor narrative centers on Synopsys as an under-the-radar AI infrastructure beneficiary—headlines tout a $2 billion Nvidia investment, partnerships with TSMC, OpenAI, and Amazon, and a raised 2027 revenue target of $11.2B—while bears counter that organic growth is being masked by Ansys consolidation and that integration costs, sharply higher interest expense, and a depressed GAAP EPS profile cloud the near-term earnings picture. The debate has produced a split verdict: sell-side targets have climbed even as the stock has de-rated from its highs, leaving investors to weigh durable AI-driven design demand against a balance sheet and margin structure still digesting a transformative deal.

People also watch

Microsoft

Microsoft

MSFT

Analysis
Palantir Technologies

Palantir Technologies

PLTR

Analysis
Oracle Corporation

Oracle Corporation

ORCL

Analysis
Palo Alto Networks

Palo Alto Networks

PANW

Analysis
CrowdStrike

CrowdStrike

CRWD

Analysis

BobbyInvestment Opinion: Should I buy SNPS Today?

Rating: Buy (accumulate), consistent with the 23-Buy/2-Hold/0-Sell consensus and a "strong_buy" mean rating of 1.28. The core thesis is that Synopsys is a duopoly EDA franchise trading at 24.4x forward non-GAAP EPS ($33.51) and 10.3x sales—a discount on forward earnings to 30x+ software peers—while the market misprices the Ansys-driven margin trough as permanent rather than transitional. The average analyst target of $589.55 implies +29.5% upside from $455.20, and even the lowest target of $475 sits 4.4% above the current price.

Supporting evidence is concrete: latest-quarter revenue of $2.48B grew 42.37% year-over-year, with a $1.0B license-and-maintenance base providing recurring visibility; Q3 GAAP net income of $545.8M (22.0% margin) was the best quarter of the year versus $17.1M in Q2 and $64.7M in Q1, suggesting the earnings trough has passed; TTM free cash flow of $2.79B against just $67M of quarterly capex covers the ~$530M annualized interest bill roughly five times over; and gross margin of 72.6% (76.98% reported) still reflects a mission-critical, subscription-like toolset embedded at TSMC, Nvidia, and hyperscalers. The $2B Nvidia investment and the raised 2027 revenue target of $11.2B reinforce the AI-infrastructure demand narrative.

The biggest risks that could invalidate this view are (1) organic growth ex-Ansys stalling beneath the 42% headline, (2) gross margin failing to recover from 72.6% toward the 78.1% pre-deal level as $455M of quarterly D&A and lower-margin Ansys hardware/services persist, and (3) multiple compression at 10.3x sales if sentiment reverses. This Buy would upgrade to a higher-conviction stance if Q4 gross margin holds above 73% and organic growth is disclosed in the mid-teens, and would downgrade to Hold if organic growth decelerates below 10% or interest coverage (currently ~2.7x) deteriorates. Verdict: fairly valued to modestly undervalued on forward earnings, expensive on sales—a premium franchise at a reasonable forward price rather than a bargain.

Sign up to view all

SNPS 12-Month Price Forecast

The forward-looking case rests on a valuation gap: at 24.4x forward non-GAAP EPS the stock trades below premium software peers even though it owns a duopoly EDA franchise with 72.6% gross margins and AI-driven design demand. The earnings trajectory supports the thesis—Q3 net income of $545.8M (22.0% margin) versus $17.1M in Q2 shows the Ansys accounting trough may have passed—while $2.79B of TTM FCF comfortably services the debt taken on for the deal. Analyst sentiment is unusually one-sided, with all 25 targets above the $455.20 price and a $589.55 average implying +29.5% upside, though the 47% spread from $475 to $700 signals real uncertainty about integration pace. I would upgrade to high confidence if Q4 confirms gross margin above 73% and discloses mid-teens organic growth, and would downgrade to neutral if organic growth slips below 10% or the stock breaks the $372–$378 support shelf.

Historical Price
Current Price $396.17
Average Target $532.27
High Target $700.00
Low Target $362.55

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Synopsys's 12-month outlook, with a consensus price target around $591.49 and implied upside of +49.3% versus the current price.

Average Target

$591.49

26 analysts

Implied Upside

+49.3%

vs. current price

Analyst Count

26

covering this stock

Price Range

$475 - $700

Analyst target range

Buy
24 (92%)
Hold
2 (8%)
Sell
0 (0%)

Coverage is deep and overwhelmingly bullish: 25 analysts cover the stock with 23 Buy ratings, 2 Hold, and 0 Sell, yielding a consensus recommendation of "strong_buy" (mean rating 1.28). The average target price of $589.55 implies roughly +29.5% upside from the current $455.20, and even the lowest target of $475 sits about 4.4% above the current price—meaning every published analyst target is above the market, a rare unanimity that signals strong conviction that the recent selloff is overdone. The consensus leans decisively bullish, with the 23-to-2 Buy/Hold split among the most lopsided in large-cap software.

The target range of $475 to $700 is wide—a 47% spread from low to high—signaling meaningful uncertainty about the pace of Ansys integration and margin recovery. The $700 high target likely assumes successful synergy capture, multiple expansion toward premium software peers, and AI-driven design demand accelerating revenue toward the $11.2B 2027 target; the $475 low target prices in modest multiple compression and slower organic growth masked by acquisition accounting. Institutional ratings show a clear upgrade cycle: HSBC moved to Buy from Hold (Sept 25), Wells Fargo to Overweight from Equal Weight (Sept 10), Morgan Stanley to Overweight from Equal Weight (Sept 8), and BNP Paribas to Neutral from Underperform (Sept 24)—a pattern of broadening bullishness that supports the consensus. The wide spread and recent upgrades suggest analysts see asymmetric upside, though the gap between the $589.55 average target and the $455.20 price also reflects how far sentiment has run ahead of the tape.

Drowning in data?

Find the real signal!

Bulls vs Bears: SNPS Investment Factors

The bear case is built on optics and the bull case on trajectory, and on balance the bull evidence is currently stronger: 23 of 25 analysts rate Buy, every target exceeds the current price, revenue is growing 42%, and $2.79B of TTM free cash flow funds a manageable debt load. The bears' strongest points—near-zero GAAP EPS, gross margin compression from 78.1% to 72.6%, and $133M quarterly interest expense—are real but largely explainable as Ansys integration accounting rather than structural deterioration. The single most important tension is whether organic growth (ex-Ansys) is durable and whether margins recover toward pre-deal levels; if Q3's improving $545.8M net income proves the start of a normalization trend, the 24.4x forward PE looks cheap, but if organic growth stalls, the 10.3x sales multiple has room to compress. The stock's mid-range technical position and the 47% analyst target spread confirm the market has not yet resolved this debate.

Bullish

  • Unanimous analyst conviction, 29.5% upside: All 25 covering analysts rate the stock Buy or Hold (23 Buy, 2 Hold, 0 Sell) with a mean rating of 1.28, and the average target of $589.55 implies +29.5% upside from $455.20. Even the lowest published target of $475 sits 4.4% above the current price, a rare unanimity suggesting the selloff is viewed as overdone.
  • Revenue inflecting 42% on Ansys: Latest-quarter revenue of $2.48B grew 42.37% year-over-year from $1.74B, lifting trailing four-quarter revenue to roughly $9.4B versus ~$6.8B a year earlier. Management's raised 2027 target of $11.2B exceeded consensus, and the $1.0B license-and-maintenance base provides recurring visibility.
  • Strong free cash flow, capital-light model: Q3 free cash flow was $746M against just $67M of capex, producing TTM FCF of $2.79B and a ~3.8% FCF yield on the $72.7B market cap. That cash flow comfortably covers the ~$530M annualized interest bill, and the company repaid $3.45B of debt in Q1 while issuing $2.01B of stock.
  • Duopoly moat with 72.6% gross margin: Synopsys is one of two dominant EDA vendors, and its 72.6% gross margin (76.98% on the reported metric) reflects mission-critical, subscription-like tools embedded in customer workflows at TSMC, Nvidia, and hyperscalers. The $2B Nvidia investment and partnerships with TSMC, OpenAI, and Amazon reinforce its position as an AI-infrastructure enabler.

Bearish

  • Organic growth masked by acquisition: The headline 42.37% revenue growth is driven overwhelmingly by Ansys consolidation rather than organic expansion, and bears argue underlying growth is being obscured. The gap between the $11.2B 2027 target and the $16.3B consensus revenue estimate also signals confusion about the true run-rate base.
  • GAAP earnings near zero, margins compressed: Trailing EPS is just $0.018, with Q2 net income of $17.1M (0.75% margin) and Q1 of $64.7M (2.7% margin) showing how thin GAAP profitability has become. Gross margin fell from 78.1% a year ago to 72.6% as lower-margin Ansys hardware/services and $455M of quarterly D&A (versus $114M) weigh on results.
  • Interest expense ballooned 9x: Quarterly interest expense has jumped to $133M from $15M a year ago, leaving interest coverage of only ~2.7x in the latest quarter. The company now depends on continued FCF growth to service debt, and the depressed 4.70% ROE and 1.35% ROA reflect the acquisition-accounting drag.
  • Stock in corrective downtrend: The stock is down 9.40% over six months and 5.25% year-to-date, underperforming SPY by 11.53 points over six months, with a -31.21% max drawdown from the July decline of ~$534 to $372. At $455.20 it sits mid-range (52% of the $362.55–$539.48 band), with lower highs since May.

SNPS Technical Analysis

Synopsys is in a choppy, range-bound consolidation rather than a clean trend: the stock is up 15.55% over the past year but down 5.25% year-to-date, and at $455.20 it sits at roughly 52% of its 52-week range of $362.55–$539.48—squarely mid-range, neither momentum-extended nor a falling knife. The 52-week high of $539.48 was set early in the window (the May 2026 area near $534), and the stock has since traced a series of lower highs punctuated by violent rallies, including the late-August spike to $464.89 and the early-October surge to $509.99. This positioning implies a market that has repriced expectations downward but repeatedly defends the low-$370s, suggesting accumulation rather than distribution at the base.

Short-term momentum is negative and diverging from the longer-term trend: the stock is down 5.15% over the past month versus a 7.99% gain over three months, and it has underperformed SPY by 2.89 percentage points in the last month even as it outperformed by 10.83 points over three months. That one-month/three-month divergence—recent weakness inside a stronger quarterly advance—looks like a mean-reversion pullback after the October run to $509.99 rather than a trend reversal, particularly since the pullback has been orderly (the November 5 dip to $440.31 was bought back to $466.97 within two sessions). The six-month change of -9.40% and relative strength of -11.53 points versus SPY confirm the intermediate trend has been corrective, and the -31.21% max drawdown underscores how sharp the July decline from ~$534 to $372 was. Volume data is unavailable (reported as zero), so momentum confirmation must rely on price structure alone.

Key technical levels are well defined: support clusters at the 52-week low of $362.55, with a secondary shelf around $372–$378 (the July/August base), while resistance sits at the 52-week high of $539.48, with intermediate supply at $510 (the October peak). A breakout above $510–$539 would signal the market is re-rating the AI/Ansys story and likely open a test of new highs; a breakdown below $372 would confirm the corrective trend and put the $362.55 low in play. With a beta of 1.184, Synopsys is roughly 18% more volatile than the market—meaningful for position sizing, as a 10% SPY drawdown would historically imply a ~12% move here, and the 31.21% max drawdown shows the stock can deliver drawdowns roughly 2.5x the market's typical correction.

Beta

1.18

1.18x market volatility

Max Drawdown

-31.2%

Largest decline past year

52-Week Range

$363-$539

Price range past year

Annual Return

+2.7%

Cumulative gain past year

PeriodSNPS ReturnS&P 500
1m-12.2%-9.7%
3m-0.4%-9.9%
6m-24.5%-7.5%
1y+2.7%+4.7%
ytd-17.5%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

SNPS Fundamental Analysis

Revenue is inflecting sharply upward, driven overwhelmingly by the Ansys consolidation: the latest quarter (ended 2026-07-31) delivered $2.48B in revenue, up 42.37% year-over-year from $1.74B, and the trailing four quarters total roughly $9.4B versus ~$6.8B in the prior-year period. Sequentially, revenue has climbed from $2.41B (Q1) to $2.28B (Q2) to $2.48B (Q3), and the mix shows license and maintenance at $1.00B, technology services at $809M, and license at $665M—a recurring-revenue-heavy base that supports visibility. Management's 2027 revenue target of $11.2B (per October news) exceeded consensus, and the analyst consensus revenue estimate of $16.3B (likely a longer-dated or post-Ansys full-year figure) implies continued double-digit-plus expansion; the key question is how much of the 42% growth is organic versus acquired, with bears arguing organic growth is being masked.

Profitability is the pressure point: GAAP net income was $545.8M in Q3 (a 22.0% net margin) but only $17.1M in Q2 (0.75% margin) and $64.7M in Q1 (2.7% margin), producing a trailing EPS of just $0.018 and a trailing PE of 55.8x on essentially no GAAP earnings. Gross margin has compressed from 78.1% a year ago to 72.6% in the latest quarter as lower-margin Ansys hardware/services revenue and $455M of quarterly D&A (versus $114M a year ago) weigh on the P&L; operating margin of 14.4% in Q3 compares to 9.5% a year ago but is well below the 23.5% posted in Q2 2025. The gap between GAAP and non-GAAP is enormous—consensus non-GAAP EPS of $33.51 versus $0.02 GAAP—reflecting acquisition amortization, stock-based compensation of $232M in Q3, and interest expense that has ballooned to $133M per quarter from $15M a year ago. The trajectory is improving (Q3 net income of $545.8M was the best quarter of the year), but margin recovery to pre-deal levels remains a multi-year project.

Balance sheet and cash flow are solid but levered: debt-to-equity is 0.50, the current ratio is 1.62, and Q3 free cash flow was $746M (TTM FCF of $2.79B), with operating cash flow of $813M against capex of just $67M—a capital-light model that throws off cash. Cash stands at $3.61B, and the company repaid $3.45B of debt in Q1 while issuing $2.01B of stock, evidence of active deleveraging post-Ansys; ROE of 4.70% and ROA of 1.35% are depressed by acquisition accounting and goodwill but should normalize as amortization rolls off. The FCF yield of roughly 3.8% ($2.79B on a $72.7B market cap) is modest for a software company, and with interest coverage of only ~2.7x in the latest quarter, the company depends on continued FCF growth to service debt—but the $2.79B TTM FCF comfortably covers the ~$530M annualized interest bill, so financial risk appears manageable rather than acute.

Quarterly Revenue

$2.5B

2026-07

Revenue YoY Growth

+42.4%

YoY Comparison

Gross Margin

72.6%

Latest Quarter

Free Cash Flow

$2.7B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

License and Maintenance
License
Technology Service

Open an Account, get $2 TSLA now!

Valuation Analysis: Is SNPS Overvalued?

Because trailing GAAP net income is effectively zero (EPS of $0.018), the trailing PE of 55.8x is not a meaningful anchor; I therefore lead with the forward PE of 24.4x on consensus non-GAAP EPS of $33.51, supplemented by the PS ratio of 10.3x and EV/Sales of 10.0x. The enormous gap between the 55.8x trailing and 24.4x forward multiple implies the market expects earnings to more than double as Ansys synergies materialize and amortization normalizes—a bet on substantial EPS recovery rather than current profitability. The PEG ratio of -1.24 is distorted by the near-zero GAAP base and should be disregarded.

Against software-infrastructure peers, Synopsys screens as a premium asset on sales but a discount on forward earnings: PS of 10.3x and EV/EBITDA of 33.6x are rich versus typical infrastructure-software multiples in the high-single digits to low-teens on sales, while the 24.4x forward PE is below the 30x+ commanded by high-growth software peers. The premium on sales is justified by Synopsys' duopoly position, 72.6% gross margin, and AI-driven design demand, but the discount on forward earnings reflects skepticism about margin recovery and the drag from $455M of quarterly D&A. The 76.98% gross margin and 13.0% operating margin place Synopsys in the upper tier of software profitability on gross basis but mid-pack on operating basis, consistent with a company mid-integration.

Historically, Synopsys has traded at a wide range of multiples: PS ranged from ~30x (Q3 2026) to ~58x (Q3 2025) and PE from 17.7x (Q4 2024, boosted by a one-time tax benefit) to over 1,300x in the Ansys-distorted Q2 2026. At a current PS of 10.3x, the stock is near the low end of its multi-year band (versus 30–58x in recent quarters), which on the surface suggests value—but the compression largely reflects the much larger post-Ansys revenue base rather than a cheaper stock. The forward PE of 24.4x versus a trailing PE that has ranged from 17x to 134x over the past two years suggests the market is pricing a normalized earnings recovery; if margins disappoint, the multiple has room to compress further, while successful integration could justify re-rating toward the 30x+ peer group.

PE

55.8x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 18x~73x

vs. Industry Avg

26.1x

Industry PE ~26.1x*

EV/EBITDA

34.3x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on the Ansys integration and the earnings quality it has produced. Trailing GAAP EPS of $0.018 and a Q2 net margin of just 0.75% show how little accounting profit the combined entity currently generates, while gross margin has compressed from 78.1% to 72.6% and quarterly D&A has jumped to $455M from $114M. Interest expense of $133M per quarter (versus $15M a year ago) leaves interest coverage of only ~2.7x, and the enormous GAAP-to-non-GAAP gap ($33.51 consensus EPS versus $0.02 reported) means reported profitability depends heavily on amortization and stock-based compensation ($232M in Q3) rolling off. Revenue concentration in EDA plus a newly acquired, lower-margin hardware/services mix adds execution risk if synergy capture slips.

Market and competitive risks are dominated by valuation and sentiment. At 10.3x sales and 33.6x EV/EBITDA, Synopsys trades at a premium to infrastructure-software peers, so any disappointment in organic growth or margin recovery could trigger multiple compression; the 47% spread between the $475 low and $700 high analyst target quantifies that uncertainty. With a beta of 1.184, the stock is roughly 18% more volatile than the market, and it has already underperformed SPY by 11.53 points over six months and 15.87 points year-to-date. Competitive pressure from Cadence in core EDA and the risk that AI-design hype outruns delivered results (headlines tout a $2B Nvidia investment and OpenAI/Amazon partnerships) mean sentiment could reverse quickly if quarterly numbers lag the narrative.

In a worst-case scenario, slower-than-expected Ansys synergies combine with stalling organic growth, forcing analysts to cut targets and the multiple to compress toward the low end of its historical band. A retest of the 52-week low of $362.55 would represent roughly -20% from the current $455.20, while a repeat of the -31.21% max drawdown would imply a price near $313 if measured from the recent $455 level. The realistic downside in an adverse scenario is therefore approximately -20% to the $362.55 low, with a more severe -30%+ outcome if the July-style selloff recurs and the $372–$378 support shelf fails.

FAQ

Ranked by severity: first, earnings-quality and integration risk — trailing GAAP EPS of $0.018, a Q2 net margin of just 0.75%, and gross margin compressed from 78.1% to 72.6% mean reported profitability hinges on $455M of quarterly D&A and $232M of quarterly SBC rolling off as planned. Second, balance-sheet leverage — interest expense has jumped to $133M per quarter from $15M a year ago, leaving interest coverage of only ~2.7x, so the ~$530M annualized interest bill depends on continued FCF growth (TTM FCF of $2.79B currently covers it about five times). Third, valuation and sentiment risk — at 10.3x sales and 33.6x EV/EBITDA, any organic-growth disappointment could trigger multiple compression, and the 47% spread between the $475 low and $700 high analyst target quantifies that uncertainty. Fourth, market/competitive risk — a beta of 1.184 means roughly 18% more volatility than the market, the stock has already underperformed SPY by 11.53 points over six months and 15.87 points YTD, and Cadence competition plus AI-hype fatigue could reverse sentiment quickly.

The scenario framework assigns a 55% probability to the base case of $475–$589.55, in which integration costs normalize, gross margin stabilizes in the low-to-mid 70s, and the stock re-rates modestly from 24.4x forward EPS toward the high-20s as the 2027 revenue target of $11.2B comes into view. The bull case carries 25% odds and a $589.55–$700 range, requiring Ansys synergies ahead of plan, gross margin recovering toward the mid-70s, and confirmed mid-teens organic growth as AI chip-design demand accelerates. The bear case has 20% odds and a $362.55–$475 range, driven by organic growth stalling below 10%, margin recovery disappointing, and a retest of the 52-week low (-20% from $455.20), with a repeat of the -31.21% drawdown implying roughly $313 if the $372–$378 support shelf fails. The base case is most likely, and its key assumption is that forward non-GAAP EPS of $33.51 is broadly achieved while gross margin stabilizes rather than fully recovering.

The answer depends on which multiple you anchor to, and that divergence is the heart of the debate. On sales, SNPS is expensive at 10.3x PS and 10.0x EV/Sales with a 33.6x EV/EBITDA, well above typical infrastructure-software peers in the high-single to low-teens on sales. On forward earnings it looks cheap: 24.4x the $33.51 consensus non-GAAP EPS versus 30x+ for high-growth software peers, and the gap between the 55.8x trailing and 24.4x forward PE implies the market expects earnings to more than double as amortization and stock-based compensation normalize. The 10.3x PS is also near the low end of the stock's own recent band (30–58x in prior quarters), though that compression largely reflects the much larger post-Ansys revenue base rather than a cheaper stock. Net verdict: fairly valued to modestly undervalued on forward earnings, premium-priced on sales — the market is paying for a normalized margin recovery it has not yet seen.

On a risk/reward basis the setup is asymmetric to the upside: all 25 covering analysts have targets above the $455.20 price (23 Buy, 2 Hold, 0 Sell), the $589.55 average implies +29.5% upside, and even the $475 low target sits 4.4% above the market. The downside is quantifiable — a retest of the $362.55 52-week low would be roughly -20%, and a repeat of the -31.21% max drawdown implies about $313 — so the reward-to-risk skew is roughly 1.5:1 to the average target versus the 52-week low. The catch is that trailing GAAP EPS of $0.018 means you are paying 24.4x forward non-GAAP earnings for a story that depends on Ansys margin recovery and organic growth that has not yet been cleanly disclosed. It is a good buy for patient investors with a multi-year horizon who can tolerate a beta of 1.184 and integration volatility; it is a poor buy for anyone who needs near-term earnings confirmation or dividend income (0% yield).

SNPS is structurally a long-term holding: it is a duopoly EDA franchise with a $1.0B quarterly license-and-maintenance base, 72.6% gross margins, and a capital-light model ($67M quarterly capex against $746M Q3 FCF) whose value compounds with AI-driven chip complexity and the 2027 revenue target of $11.2B. The near-term picture argues against short-term trading — the stock is down 5.15% over one month, 9.40% over six months, and 5.25% YTD, sits mid-range at 52% of its 52-week band, and has a beta of 1.184 with a -31.21% max drawdown, meaning momentum is unresolved and drawdowns can be roughly 2.5x a typical market correction. There is no dividend (0% yield, 0% payout), so there is no income component to smooth the wait. A concrete minimum holding period of 18–24 months is appropriate — long enough to span the Ansys integration, the gross-margin recovery, and at least one full disclosure cycle on organic growth — with position sizing that assumes a 20–30% drawdown is possible along the way.